Cargando…
Inflammation Amplification by Versican: The First Mediator
The effects of inflammation may not always benefit the individual. Its amplifying nature represents a highly regulated biological program, and the inflammatory microenvironment is its essential component. Growing evidence suggests that the ECM (extracellular matrix) is important for the early steps...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397501/ https://www.ncbi.nlm.nih.gov/pubmed/22837669 http://dx.doi.org/10.3390/ijms13066873 |
_version_ | 1782238192881106944 |
---|---|
author | Zhang, Zhenwei Miao, Lei Wang, Lianghua |
author_facet | Zhang, Zhenwei Miao, Lei Wang, Lianghua |
author_sort | Zhang, Zhenwei |
collection | PubMed |
description | The effects of inflammation may not always benefit the individual. Its amplifying nature represents a highly regulated biological program, and the inflammatory microenvironment is its essential component. Growing evidence suggests that the ECM (extracellular matrix) is important for the early steps of inflammation. Versican, a ubiquitous component of the ECM, contributes to the formation of the inflammatory response and is highly regulated by cytokines. Certain cytokines exert their initial effects on versican to alter the homeostasis of the inflammatory milieu, and inappropriate production of versican may promote the next inflammatory response. Therefore, versican could be the first step in the amplification of the inflammatory response, and ongoing research of this molecule may help to explain the pathogenesis of inflammation. |
format | Online Article Text |
id | pubmed-3397501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Molecular Diversity Preservation International (MDPI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-33975012012-07-26 Inflammation Amplification by Versican: The First Mediator Zhang, Zhenwei Miao, Lei Wang, Lianghua Int J Mol Sci Opinion The effects of inflammation may not always benefit the individual. Its amplifying nature represents a highly regulated biological program, and the inflammatory microenvironment is its essential component. Growing evidence suggests that the ECM (extracellular matrix) is important for the early steps of inflammation. Versican, a ubiquitous component of the ECM, contributes to the formation of the inflammatory response and is highly regulated by cytokines. Certain cytokines exert their initial effects on versican to alter the homeostasis of the inflammatory milieu, and inappropriate production of versican may promote the next inflammatory response. Therefore, versican could be the first step in the amplification of the inflammatory response, and ongoing research of this molecule may help to explain the pathogenesis of inflammation. Molecular Diversity Preservation International (MDPI) 2012-06-06 /pmc/articles/PMC3397501/ /pubmed/22837669 http://dx.doi.org/10.3390/ijms13066873 Text en © 2012 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Opinion Zhang, Zhenwei Miao, Lei Wang, Lianghua Inflammation Amplification by Versican: The First Mediator |
title | Inflammation Amplification by Versican: The First Mediator |
title_full | Inflammation Amplification by Versican: The First Mediator |
title_fullStr | Inflammation Amplification by Versican: The First Mediator |
title_full_unstemmed | Inflammation Amplification by Versican: The First Mediator |
title_short | Inflammation Amplification by Versican: The First Mediator |
title_sort | inflammation amplification by versican: the first mediator |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397501/ https://www.ncbi.nlm.nih.gov/pubmed/22837669 http://dx.doi.org/10.3390/ijms13066873 |
work_keys_str_mv | AT zhangzhenwei inflammationamplificationbyversicanthefirstmediator AT miaolei inflammationamplificationbyversicanthefirstmediator AT wanglianghua inflammationamplificationbyversicanthefirstmediator |